ABEONA THERAPEUTICS INC (ABEO) Institutional Buying Activity

Institutional investors tracked by InsiderSet increased exposure to ABEONA THERAPEUTICS INC (ABEO) during the quarter ended March 31, 2026 through a combination of new purchases and expanded existing positions disclosed in SEC Form 13F filings.

The largest institutional buyer of ABEO during the latest reporting period was Renaissance Technologies LLC, which increased its reported ABEO position by approximately $1.82M based on quarter-end filing values. Several additional hedge funds and long-term asset managers also reported meaningful increases in ABEO exposure during the quarter.

Institutional buying activity can provide insight into investor conviction, sector allocation trends, and smart money positioning toward ABEONA THERAPEUTICS INC (ABEO). InsiderSet tracks quarterly accumulation trends, new institutional positions, ownership increases, and estimated performance of newly disclosed holdings using SEC filing data and recent market prices.

The investors highlighted on this page collectively added approximately $4.38M in reported ABEO exposure during the latest filing period, reflecting continued institutional interest in ABEONA THERAPEUTICS INC's growth initiatives and strategic positioning.

Portfolio quarterNameTypeQuantityRemainingReported stock balance
Q1 2026Renaissance Technologies LLCBuy44,882161,082$721,647
Q3 2025Renaissance Technologies LLCBuy226,500526,437$2,779,587
Q2 2025Renaissance Technologies LLCBuy168,400299,937$1,703,642
Q1 2025Renaissance Technologies LLCBuy42,300131,537$626,116
Q2 2024Renaissance Technologies LLCBuy429,456503,293$2,133,962
Q4 2023Renaissance Technologies LLCBuy151,556182,393$914
Q3 2022Renaissance Technologies LLCBuy68,13768,137$207

Frequently asked questions about ABEO activity

  • Which institutional owners are buying ABEO?

    Institutional owners buying ABEO include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.

  • What does "buy" mean in ABEO activity?

    "Buy" means an investor increased their reported position in ABEO compared to the prior reporting period. This reflects growing exposure to ABEONA THERAPEUTICS INC (ABEO) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).

  • Is institutional interest in ABEO increasing?

    Institutional interest in ABEO can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.